Reorganization of circuits underlying cerebellar modulation of prefrontal cortical dopamine in mouse models of autism spectrum disorder

Cerebellum

Volumn 12, Issue 4, 2013, Pages 547-556

  Rogers, Tiffany D ^a   Dickson, Price E ^a   McKimm, Eric ^a   Heck, Detlef H ^b   Goldowitz, Dan ^c   Blaha, Charles D ^a   Mittleman, Guy ^a  

^a University of Memphis   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autism spectrum disorders; Cerebellum; Dopamine; Fragile X; Lurcher; Prefrontal cortex

Indexed keywords

KYNURENIC ACID; LIDOCAINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BRAIN REGION; CELL LOSS; CEREBELLUM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; EVOKED RESPONSE; FRAGILE X SYNDROME; MOUSE; NEUROMODULATION; NEUROPATHOLOGY; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PURKINJE CELL; VENTRAL TEGMENTUM;

EID: 84892366098     PISSN: 14734222     EISSN: 14734230     Source Type: Journal    
DOI: 10.1007/s12311-013-0462-2     Document Type: Article

References (64)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders-IV-TR. 4th ed. Washington: American Psychiatric Association; 2000.
2. Ozonoff S, South M, Provencal S. Executive functions in autism: Theory and practice. In Pérez JM, González PM, Comí MC, et al., editors. New developments in autism: the future is today. Philadelphia: Asociación de Padres de Personas con Autismo; 2007. pp 185-213.
3. Bandim JM, Ventura LO, Miller MT, Almeida HC, Costa AES. Autism and Möbius sequence: an exploratory study of children in northeastern Brazil. Arq Neuropsiquiatr. 2003;61:181-5.
4. Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev. 2012;22:229-37.
5. Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ,Montgomery T, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000;37:489-97.
6. Muhle R, Trentacoste SV, Rapin I. The genetics of autism. Pediatrics. 2004;113:472-86.
7. Rodier PM. Converging evidence for brain stem injury in autism. Dev Psychopathol. 2002;14:537-57.
8. Bauman ML. Microscopic neuroanatomic abnormalities in autism. Pediatrics. 1991;87:791-6.
9. Courchesne E. Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism. Curr Opin Neurobiol. 1997;7:269-78.
10. Courchesne E, Townsend J, Akshoomoff NA, Saitoh O, Yeung-Courchesne R, Lincoln AJ, et al. Impairment in shifting attention in autistic and cerebellar patients. Behav Neurosci. 1994;108:848-65.
11. Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N Engl J Med. 1988;318:1349-54.
12. DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The developmental neurobiology of autism spectrum disorder. J Neurosci. 2006;26:6897-906.
13. Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain. 2004;127:2572-83.
14. Webb SJ, Sparks BF, Friedman SD, Shaw DW, Giedd J, Dawson G, et al. Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res. 2009;172:61-7.
15. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci. 2005;23:183-7.
16. Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, et al. A clinicopathological study of autism. Brain. 1998;121:889-905.
17. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol. 2005;57:67-81.
18. Caddy KW, Biscoe TJ. Structural and quantitative studies on the normal C3H and Lurcher mutant mouse. Philos Trans R Soc Lond. 1979;287:167-201.
19. Zuo J, De Jager PL, Takahashi KA, Jiang W, Linden DJ, Heintz N. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature. 1997;388:769-73.
20. Goldowitz D, Moran H, Wetts R. Mouse chimeras in the study of genetic and structural determinants of behavior. In: Goldowitz D, Wahlsten D, Wimer RE, editors. Techniques for the genetic analysis of brain and behavior: focus on the mouse. Amsterdam: Elsevier; 1992. p. 271-90.
21. Martin LA, Goldowitz D, Mittleman G. Repetitive behavior and increased activity in mice with Purkinje cell loss: a model for understanding the role of cerebellar pathology in autism. Eur J Neurosci. 2010;31:544-55.
22. Dickson PE, Rogers TD, Del Mar N, Martin LA, Heck D, Blaha CD, et al. Behavioral flexibility in a mouse model of developmental cerebellar Purkinje cell loss. Neurobiol Learn Mem. 2010;94:220-8.
23. Mittleman G, Goldowitz D, Heck DH, Blaha CD. Cerebellar modulation of frontal cortex dopamine efflux in mice: relevance to autism and schizophrenia. Synapse. 2008;62:544-50.
24. Forster GL, Blaha CD. Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur J Neurosci. 2003;17:751-62.
25. Garcia-Rill E, SkinnerRD, MiyazatoH, HommaY. Pedunculopontine stimulation induces prolonged activation of pontine reticular neurons. Neuroscience. 2001;104:455-65.
26. Perciavalle V, Berretta S, Raffaele R. Projections from the intracerebellar nuclei to the ventral midbrain tegmentum in the rat. Neuroscience. 1989;29:109-19.
27. Schwarz C, Schmitz Y. Projection from the cerebellar lateral nucleus to precerebellar nuclei in the mossy fiber pathway is glutamatergic: a study combining anterograde tracing with immunogold labeling in the rat. J Comp Neurol. 1997;381:320-34.
28. Snider RS, Maiti A, Snider SR. Cerebellar pathways to ventral midbrain and nigra. Exp Neurol. 1976;53:714-28.
29. Del Arco A, Mora F. Glutamate-dopamine in vivo interaction in the prefrontal cortex modulates the release of dopamine and acetylcholine in the nucleus accumbens of the awake rat. J Neural Transm. 2005;112:97-109.
30. Middleton FA, Strick PL. Cerebellar projections to the prefrontal cortex of the primate. J Neurosci. 2001;21:700-12.
31. Pinto A, Jankowski M, Sesack SR. Projections from the paraventricular nucleus of the thalamus to the rat prefrontal cortex and nucleus accumbens shell: ultrastructural characteristics and spatial relationships with dopamine afferents. J Comp Neurol. 2003;459:142-55.
32. Rogers TD, Dickson PE, Heck DH, Goldowitz D, Mittleman G, Blaha CD. Connecting the dots of the cerebro-cerebellar role in cognitive function: neuronal pathways for cerebellar modulation of dopamine release in the prefrontal cortex. Synapse. 2011;65:1204-12.
33. Goodrich-Hunsaker NJ, Wong LM, McLennan Y, Tassone F, Harvey D, Rivera SM, et al. Adult female fragile X permutation carriers exhibit age-and CGG repeat length-related impairments on an attentionally based enumeration task. Front Hum Neurosci. 2011;5:63.
34. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991;65:905-14.
35. Ellegood J, Pacey LK, Hampson DR, Lerch JP, Henkelman RM. Anatomical phenotyping in a mouse model of Fragile X syndrome with magnetic resonance imaging. NeuroImage. 2010;53:1023-9.
36. Koekkoek SK, Yamaguchi K, Milojkovic BA, Dortland BR, Ruigrok TJ, Maex R, et al. Deletion of Fmr1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome. Neuron. 2005;47:339-52.
37. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. 2nd ed. San Diego: Academic; 2001.
38. Linnemann C, Sultan F, Pedroarena CM, Schwarz C, Thier P. Lurcher mice exhibit potentiation of GABA(A)-receptor-mediated conductance in cerebellar nuclei neurons in close temporal relationship to Purkinje cell death. J Neurophysiol. 2004;91:1102-7.
39. The Dutch-Belgian Fragile X Consortium. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell. 1994;78:23-33.
40. Kooy RF, D'Hooge R, Reyniers E, Bakker CE, Nagels G, De Boulle K, et al. Transgenic mouse model for the fragile X syndrome. Am J Med Genet. 1996;64:241-5.
41. D'Hooge R, Nagels G, Franck F, Bakker CE, Reyniers E, Storm K, et al. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience. 1997;76:367-76.
42. Bontekoe CJ, McIlwain KL, Nieuwenhuizen IM, Yuva-Paylor LA, Nellis A, Willemsen R, et al. Knockout mouse model for Fxr2: a model for mental retardation. Hum Mol Genet. 2002;11:487-98.
43. Greco CM, Navarro CS, Hunsaker MR, Maezawa I, Shuler JF, Tassone F, et al. Neuropathologic features in the hippocampus and cerebellum of three older men with fragile X syndrome. Mol Autism. 2011;2:2.
44. Sabaratnam M. Pathological and neuropathological findings in two males with fragile-X syndrome. J Intellect Disabil Res. 2000;44:81-5.
45. Hallahan B, Daly EM, McAlonan G, Loth E, Toal F, O'Brien F, et al. Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults. Psychol Med. 2009;39:337-46.
46. McKelvey JR, Lambert R, Mottron L, Shevell MI. Righthemisphere dysfunction in Asperger's syndrome. J Child Neurol. 1995;10:310-4.
47. Yu KK, Cheung C, Chua SE, McAlonan GM. Can Asperger syndrome be distinguished from autism? An anatomic likelihood meta-analysis of MRI studies. J Psychiatry Neurosci. 2011;36:412-21.
48. Murakami JW, Courchesne E, Haas RH, Press GA, Yeung-Courchesne R. Cerebellar and cerebral abnormalities in Rett syndrome: a quantitative MR analysis. Am J Roentgenol. 1992;159:177-83.
49. Oldfors A, Sourander P, Armstrong DL, Percy AK,Witt-Engerström I, Hagberg BA. Rett syndrome: cerebellar pathology. Pediatr Neurol. 1990;6:310-4.
50. Carper RA, Courchesne E. Localized enlargement of the frontal lobe in autism. Biol Psychiatry. 2005;57:126-33.
51. Kumar A, Sundaram SK, Sivaswamy L, Behen ME, Makki MI, Ager J, et al. Alterations in frontal lobe tracts and corpus callosum in young children with autism spectrum disorder. Cereb Cortex. 2010;20:2103-13.
52. Carper RA, Courchesne E. Inverse correlation between frontal lobe and cerebellum sizes in children with autism. Brain. 2000;123:836-44.
53. Hardan AY, Girgus RR, Adams J, Gilbert AR, Keshaven MS, Minshew NJ. Abnormal brain size effect on the thalamus in autism. Psychiatry Res. 2006;147:145-51.
54. Tamura R, Kitamura H, Endo T, Hasegawa N, Someya T. Reduced thalamic volume observed across different subgroups of autism spectrum disorders. Psychiatry Res. 2010;184:186-8.
55. Tsatsanis KD, Rourke BP, Klin A, Colkmar FR, Cicchetti D, Schultz RT. Reduced thalamic volume in high-functioning individuals with autism. Biol Psychiatry. 2003;53:121-9.
56. Estes A, Shaw DW, Sparks BF, Friedman S, Giedd JN, Dawson G, et al. Basal ganglia morphometry and repetitive behavior in young children with autism spectrum disorder. Autism Res. 2011;4:212-20.
57. Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM. Low medial prefrontal dopaminergic activity in autistic children. Lancet. 1997;350:638.
58. Aalto S, Brüch A, Laine M, Rinne J. Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the highaffinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci. 2005;25:2471-7.
59. Gamo NJ, Wang M, Arnsten AF. Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors. J Am Acad Child Adolesc Psychiatry. 2010;49:1011-23.
60. Jackson ME, Moghaddam B. Stimulus-specific plasticity of prefrontal cortex dopamine neurotransmission. J Neurochem. 2004;88:1327-34.
61. Rose J, Schiffer A-M, Dittrich L, Güntürkün O. The roles of dopamine in maintenance and distractibility of attention in the "prefrontal cortex" of pigeons. Neuroscience. 2010;167:232-7.
62. Reader TA, Strazielle C, Botez MI, Lalonde R. Brain dopamine and amino acid concentrations in Lurcher mutant mice. Brain Res Bull. 1998;15:489-93.
63. Strazielle C, Lalonde R, Amdiss F, Botez MI, Hébert C, Reader TA. Distribution of dopamine transporters in basal ganglia of cerebellar ataxic mice by [125I]RTI-121 quantitative autoradiography. Neurochem Int. 1998;32:61-8.
64. Myslivecek J, Cendelín J, Korelusová I, Kunová M, Markvartová V, Vozeh F. Changes of dopamine receptors in mice with olivocerebellar degeneration. Prague Med Rep. 2007;108:57-66. Stroke